Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Cell cycle signaling and cardiovascular disease.

Nabel EG, Boehm M, Akyurek LM, Yoshimoto T, Crook MF, Olive M, San H, Qu X.

Cold Spring Harb Symp Quant Biol. 2002;67:163-70. No abstract available.

PMID:
12858537
2.

p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.

Luedde T, Rodriguez ME, Tacke F, Xiong Y, Brenner DA, Trautwein C.

Hepatology. 2003 Apr;37(4):833-41.

PMID:
12668976
3.

Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models.

Jackson RJ, Adnane J, Coppola D, Cantor A, Sebti SM, Pledger WJ.

Oncogene. 2002 Dec 5;21(55):8486-97.

4.

[Role of the p27 cell-cycle inhibitor during vascular remodeling].

Andrés V, Díez-Juan A.

Nefrologia. 2002;22 Suppl 5:17-20. Review. Spanish. No abstract available.

5.

Ras and Rho regulation of the cell cycle and oncogenesis.

Pruitt K, Der CJ.

Cancer Lett. 2001 Sep 28;171(1):1-10. Review.

PMID:
11485822
6.

The rapamycin derivative RAD inhibits mesangial cell migration through the CDK-inhibitor p27KIP1.

Daniel C, Pippin J, Shankland SJ, Hugo C.

Lab Invest. 2004 May;84(5):588-96.

7.

Cell signaling in injured rat arteries.

Koyama H, Olson NE, Reidy MA.

Thromb Haemost. 1999 Aug;82(2):806-9. Review. No abstract available.

PMID:
10605786
8.

Not just an inhibitor: a role for p21 beyond the cell cycle-"The truth is rarely pure and never simple".

Griffin SV, Shankland SJ.

J Am Soc Nephrol. 2004 Mar;15(3):825-6. No abstract available.

9.
10.

Cyclins and CDKS in development and cancer: lessons from genetically modified mice.

Santamaria D, Ortega S.

Front Biosci. 2006 Jan 1;11:1164-88. Review.

PMID:
16146805
12.

p27kip1 contributions to cancer.

Nho RS, Sheaff RJ.

Prog Cell Cycle Res. 2003;5:249-59. Review.

PMID:
14593719
13.

Unexpected proatherogenic properties of p21: beyond cell cycle control?

Andrés V.

Circulation. 2004 Dec 21;110(25):3749-52. No abstract available.

14.

Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.

Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, Sclafani RA, Agarwal R.

Oncogene. 2003 Nov 13;22(51):8271-82.

PMID:
14614451
15.
16.

The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy.

Verdoodt B, Blazek T, Rauch P, Schuler G, Steinkasserer A, Lutz MB, Funk JO.

Eur J Immunol. 2003 Nov;33(11):3154-63.

17.

Histochemical examination of periodontal junctional epithelium in p21/p27 double knockout mice.

Watanabe K, Petro BJ, Sevandal M, Anshuman S, Jovanovic A, Tyner AL.

Eur J Oral Sci. 2004 Jun;112(3):253-8.

PMID:
15154924
19.

Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.

Scott SA, Kimura T, Dong WF, Ichinohasama R, Bergen S, Kerviche A, Sheridan D, DeCoteau JF.

Leuk Res. 2004 Dec;28(12):1293-301.

PMID:
15475071
20.

Supplemental Content

Support Center